MIMS Benefits
- Lower risk of complications - minimally invasive and stent-less
- Accessible to wide range of ophthalmologists - simple and very quick to use
- Cost-effective
- Medication-sparing which improves quality of life for patients
- Suitable for most Glaucoma patients
- Can be easily combined with Cataract surgery, thus, enables access to larger markets